Rituximab in the management of chronic immune thrombocytopenic purpura: an effective and safe therapeutic alternative in refractory patients
暂无分享，去创建一个
V. Jiménez‐Yuste | I. Millán | P. Giraldo | F. Peñalver | D. Caballero | M. Rodríguez | A. Álvarez-Larrán | L. Gallur | J. Mayans | M. Almagro | R. González | M. Casado | J. Cabrera | R. Hernández | L. Rodríguez | D. Menor | On behalf of the Multi-institutional Retrospective Sp Itp | I. Millán